Industry Threatens to Reverse EPA Ban on Toxic Chemical Linked to Parkinson's

More than 1 million Americans are living with Parkinson’s disease today, and this neurodegenerative disorder affects nearly 10 million people worldwide.1 But even as diagnoses surge, industries tied to manufacturing and defense are fighting to keep one of the most well-documented environmental triggers on the market — trichloroethylene (TCE). A clear, volatile solvent used for…

This Gene Therapy Startup Wants to Change the Way We Age

Opinions expressed by Entrepreneur contributors are their own. What if you could slow aging and improve your biological function with a single 30-second shot? That’s the promise behind Minicircle, a gene therapy startup with lofty ambitions. As Founder and CEO Mac Davis put it recently on the One Day with Jon Bier podcast: “We want…

Making the next generation of megacities

Megacities do not arise from size alone. They emerge by carefully synthesizing infrastructure, ecosystems, and human behavior. A truly functional urban center grows from a systemic design that prioritizes intelligence in layout, environmental stewardship, and social inclusion. As land availability contracts and climate variability accelerates, the challenge of urbanization shifts from expansion to transformation. Mobility…

Isack Hadjar and Liam Lawson looking forward to the ‘atmosphere’ of the Miami GP

The Formula 1 grid returns to the United States this weekend with the Miami Grand Prix, the fourth installment of one of the newest races on the schedule. The Miami Grand Prix has one of the more unique settings on the schedule, as the circuit winds around Hard Rock Stadium, home of the Miami Dolphins….

More and more older Americans want to know their Alzheimer’s status, survey finds : Shots

A survey of older Americans found that 79% would want to know if they were in the early stages of Alzheimer’s, and 92% said that if diagnosed, they would probably or definitely want to take a drug that could slow down the disease’s progression. The results may indicate a recent shift in openness toward Alzheimer’s…